Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.

SEHK:1349 주식 보고서

시가총액: HK$5.6b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd 대차 대조표 상태

재무 상태 기준 확인 6/6

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd 의 총 주주 지분은 CN¥2.4B 이고 총 부채는 CN¥0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 CN¥2.8B 및 CN¥464.5M 입니다. Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd 의 EBIT는 CN¥70.9M 이며 이자보상배율은 -13.3 입니다. CN¥1.2B 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

0%

부채 비율

CN¥0

부채

이자 보상 비율-13.3x
현금CN¥1.23b
주식CN¥2.36b
총 부채CN¥464.49m
총 자산CN¥2.83b

최근 재무 상태 업데이트

Recent updates

Earnings Troubles May Signal Larger Issues for Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd (HKG:1349) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd (HKG:1349) Shareholders

What To Know Before Buying Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) For Its Dividend

Apr 12
What To Know Before Buying Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) For Its Dividend

We Think Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Can Manage Its Debt With Ease

Mar 22
We Think Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Can Manage Its Debt With Ease

Should You Be Adding Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) To Your Watchlist Today?

Mar 07
Should You Be Adding Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) To Your Watchlist Today?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s HKG:1349) Stock?

Feb 20
Are Strong Financial Prospects The Force That Is Driving The Momentum In Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s HKG:1349) Stock?

Could The Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) Ownership Structure Tell Us Something Useful?

Feb 07
Could The Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) Ownership Structure Tell Us Something Useful?

Should Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Be Disappointed With Their 38% Profit?

Jan 25
Should Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Be Disappointed With Their 38% Profit?

Should You Rely On Shanghai Fudan-Zhangjiang Bio-Pharmaceutical's (HKG:1349) Earnings Growth?

Jan 12
Should You Rely On Shanghai Fudan-Zhangjiang Bio-Pharmaceutical's (HKG:1349) Earnings Growth?

Would Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) Be Valuable To Income Investors?

Dec 28
Would Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) Be Valuable To Income Investors?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Seems To Use Debt Rather Sparingly

Dec 15
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Seems To Use Debt Rather Sparingly

Should You Be Adding Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) To Your Watchlist Today?

Dec 03
Should You Be Adding Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) To Your Watchlist Today?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s (HKG:1349) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Nov 21
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s (HKG:1349) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

재무 상태 분석

단기부채: 1349 의 단기 자산 ( CN¥1.8B )이 단기 부채( CN¥453.0M ).

장기 부채: 1349 의 단기 자산( CN¥1.8B )이 장기 부채( CN¥11.4M ).


부채 대 자본 내역 및 분석

부채 수준: 1349 부채가 없습니다.

부채 감소: 1349 는) 부채 대 자기자본 비율이 15.7% 였던 5년 전과 비교하여 부채가 없습니다.

부채 범위: 1349 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: 1349 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.


대차 대조표


건강한 기업 발견하기